{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:00:03Z","timestamp":1790647203760,"version":"4.1.0"},"reference-count":30,"publisher":"Journal of Biomedical Research","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2026]]},"DOI":"10.7555\/jbr.39.20250322","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T11:47:29Z","timestamp":1762948049000},"page":"553","source":"Crossref","is-referenced-by-count":0,"title":["Glycated albumin and composite glycemic-lipid indices: Complementary tools for type 2 diabetes diagnosis"],"prefix":"10.7555","volume":"40","author":[{"given":"Vera","family":"Luki\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Nini\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"D\u017eingala\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sla\u0111ana","family":"Menkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ru\u017eanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Milinkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.1","unstructured":"IDF. The diabetes atlas[EB\/OL]. (2021-12-06) [2025-03-20]. http:\/\/www.diabetesatlas.org."},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.2","doi-asserted-by":"publisher","unstructured":"Dozio E, Di Gaetano N, Findeisen P, et al. Glycated albumin: From biochemistry and laboratory medicine to clinical practice[J]. <i>Endocrine<\/i>, 2017, 55(3): 682\u2013690.","DOI":"10.1007\/s12020-016-1091-6"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"Kirkman MS, Sacks DB. Glycated albumin: Added value or redundancy in diabetes care?[J]. <i>Clin Chem<\/i>, 2022, 68(3): 379\u2013381.","DOI":"10.1093\/clinchem\/hvab261"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus[J]. <i>Diabetes Care<\/i>, 2023, 46(10): e151\u2013e199.","DOI":"10.2337\/dci23-0036"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Shimizu I, Kohzuma T, Koga M. A proposed glycemic control marker for the future: Glycated albumin[J]. <i>J Lab Precis Med<\/i>, 2019, 4: 23.","DOI":"10.21037\/jlpm.2019.05.01"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Ueda Y, Matsumoto H. Recent topics in chemical and clinical research on glycated albumin[J]. <i>J Diabetes Sci Technol<\/i>, 2015, 9(2): 177\u2013182.","DOI":"10.1177\/1932296814567225"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Tang M, Berg AH, Zheng H, et al. Glycated albumin and adverse clinical outcomes in patients with CKD: A prospective cohort study[J]. <i>Am J Kidney Dis<\/i>, 2024, 84(3): 329\u2013338.","DOI":"10.1053\/j.ajkd.2024.02.006"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Shin KS, Park MS, Lee MY, et al. Baseline glycated albumin level and risk of type 2 diabetes mellitus in healthy individuals: A retrospective longitudinal observation in Korea[J]. <i>Scand J Clin Lab Invest<\/i>, 2024, 84(3): 168\u2013173.","DOI":"10.1080\/00365513.2024.2341412"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"Zendjabil M. Glycated albumin[J]. <i>Clin Chim Acta<\/i>, 2020, 502: 240\u2013244.","DOI":"10.1016\/j.cca.2019.11.007"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.10","doi-asserted-by":"publisher","unstructured":"Kurtkulagi O, Aktas G, Taslamacioglu Duman T, et al. Correlation between serum triglyceride to HDL cholesterol ratio and blood pressure in patients with primary hypertension[J]. <i>Precision Med Sci<\/i>, 2022, 11(3): 100\u2013105.","DOI":"10.1002\/prm2.12080"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Bilgin S, Aktas G, Atak Tel BM, et al. Triglyceride to high density lipoprotein cholesterol ratio is elevated in patients with complicated type 2 diabetes mellitus[J]. <i>Acta Fac Med Naissensis<\/i>, 2022, 39(1): 66\u201373.","DOI":"10.5937\/afmnai39-33239"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Kurtkulagi O, Bilgin S, Kahveci GB, et al. Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?[J]. <i>Exp Biomed Res<\/i>, 2021, 4(3): 224\u2013229.","DOI":"10.30714\/j-ebr.2021370081"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.13","doi-asserted-by":"publisher","unstructured":"Roohk HV, Zaidi AR, Patel D. Glycated albumin (GA) and inflammation: Role of GA as a potential marker of inflammation[J]. <i>Inflamm Res<\/i>, 2018, 67(1): 21\u201330.","DOI":"10.1007\/s00011-017-1089-4"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"Verg\u00e8s B. Pathophysiology of diabetic dyslipidaemia: Where are we?[J]. <i>Diabetologia<\/i>, 2015, 58(5): 886\u2013899.","DOI":"10.1007\/s00125-015-3525-8"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.15","doi-asserted-by":"publisher","unstructured":"Yan Z, Xu Y, Li K, et al. Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus: Dual evidence from NHANES database and Mendelian randomization analysis[J]. <i>Front Endocrinol<\/i>, 2024, 15: 1272314.","DOI":"10.3389\/fendo.2024.1272314"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Martagon AJ, Zubir\u00e1n R, Gonz\u00e1lez-Arellanes R, et al. HDL abnormalities in type 2 diabetes: Clinical implications[J]. <i>Atherosclerosis<\/i>, 2024, 394: 117213.","DOI":"10.1016\/j.atherosclerosis.2023.117213"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Kouzuma T, Usami T, Yamakoshi M, et al. An enzymatic method for the measurement of glycated albumin in biological samples[J]. <i>Clin Chim Acta<\/i>, 2002, 324(1-2): 61\u201371.","DOI":"10.1016\/S0009-8981(02)00207-3"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"Fang M, Daya N, Coresh J, et al. Glycated albumin for the diagnosis of diabetes in US adults[J]. <i>Clin Chem<\/i>, 2022, 68(3): 413\u2013421.","DOI":"10.1093\/clinchem\/hvab231"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Cheng P, Neugaard B, Foulis P, et al. Hemoglobin A1c as a predictor of incident diabetes[J]. <i>Diabetes Care<\/i>, 2011, 34(3): 610\u2013615.","DOI":"10.2337\/dc10-0625"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"Butler AE, English E, Kilpatrick ES, et al. Diagnosing type 2 diabetes using hemoglobin A1c: A systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications[J]. <i>Acta Diabetol<\/i>, 2021, 58(3): 279\u2013300.","DOI":"10.1007\/s00592-020-01606-5"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"Bellia C, Zaninotto M, Cosma C, et al. Definition of the upper reference limit of glycated albumin in blood donors from Italy[J]. <i>Clin Chem Lab Med<\/i>, 2017, 56(1): 120\u2013125.","DOI":"10.1515\/cclm-2017-0179"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Testa R, Ceriotti F, Guerra E, et al. Glycated albumin: Correlation to HbA<sub>1c<\/sub> and preliminary reference interval evaluation[J]. <i>Clin Chem Lab Med<\/i>, 2017, 55(2): e31\u2013e33.","DOI":"10.1515\/cclm-2016-0512"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"Selvin E, Warren B, He X, et al. Establishment of community-based reference intervals for fructosamine, glycated albumin, and 1, 5-anhydroglucitol[J]. <i>Clin Chem<\/i>, 2018, 64(5): 843\u2013850.","DOI":"10.1373\/clinchem.2017.285742"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Chume FC, Kieling MH, Freitas PAC, et al. Glycated albumin as a diagnostic tool in diabetes: An alternative or an additional test?[J]. <i>PLoS One<\/i>, 2019, 14(12): e0227065.","DOI":"10.1371\/journal.pone.0227065"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"Chume FC, Freitas PAC, Schiavenin LG, et al. Glycated albumin in diabetes mellitus: A meta-analysis of diagnostic test accuracy[J]. <i>Clin Chem Lab Med<\/i>, 2022, 60(7): 961\u2013974.","DOI":"10.1515\/cclm-2022-0105"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.26","doi-asserted-by":"publisher","unstructured":"Lenters-Westra E, Atkin SL, Kilpatrick ES, et al. Limitations of glycated albumin standardization when applied to the assessment of diabetes patients[J]. <i>Clin Chem Lab Med<\/i>, 2024, 62(12): 2526\u20132533.","DOI":"10.1515\/cclm-2024-0591"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Hassanein M, Shafi T. Assessment of glycemia in chronic kidney disease[J]. <i>BMC Med<\/i>, 2022, 20(1): 117.","DOI":"10.1186\/s12916-022-02316-1"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Cao C, Hu H, Zheng X, et al. Non-linear relationship between high-density lipoprotein cholesterol and incident diabetes mellitus: A secondary retrospective analysis based on a Japanese cohort study[J]. <i>BMC Endocr Disord<\/i>, 2022, 22(1): 163.","DOI":"10.1186\/s12902-022-01074-8"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.29","doi-asserted-by":"publisher","unstructured":"Denimal D. Antioxidant and anti-inflammatory functions of high-density lipoprotein in type 1 and type 2 diabetes[J]. <i>Antioxidants (Basel)<\/i>, 2023, 13(1): 57.","DOI":"10.3390\/antiox13010057"},{"key":"10.7555\/JBR.39.20250322.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"Aarsand AK, D\u00edaz-Garz\u00f3n J, Fernandez-Calle P, et al. The EuBIVAS: Within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose[J]. <i>Clin Chem<\/i>, 2018, 64(9): 1380\u20131393.","DOI":"10.1373\/clinchem.2018.288415"}],"container-title":["Journal of Biomedical Research"],"original-title":[],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:08:34Z","timestamp":1790644114000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.39.20250322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"alternative-id":["JBR-2025-0322"],"URL":"https:\/\/doi.org\/10.7555\/jbr.39.20250322","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}